39results about How to "Increasing migration" patented technology

The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and / or an inflammatory disease in an individual using such pharmaceutical compositions.

The present invention is a fuel cell power plant that includes a fuel cell having a membrane electrode assembly (MEA), which is disposed between an anode support plate and a cathode support plate, and porous water transport plates adjacent the anode and cathode support plates. The porous water transport plates have interdigitated flow channels for the reactant gas streams to pass therethrough and conventional flow channels for a coolant stream to pass therethrough. The fuel cell power plant also has means for creating a pressure differential between the reactant gas streams and the coolant stream such that the pressure of the reactant gas streams is greater than the coolant stream. Incorporating the interdigitated flow channels into the porous water transport plates and operating the fuel cell at a pressure differential allows the coolant water to saturate the water transport plates thereby forcing the reactant gases into the anode and cathode support plate. This, in turn, increases the mass transfer of such gases into the support plates, thereby increasing the electrical performance of the fuel cell. Current densities of about 1.6 amps per square meter are achieved with air stochiometries of not over 2.50.

A composition for whitening teeth being an anhydrous mixture of a polyol carrier material, a stabilized oxidizing agent, and a surfactant, the mixture having a viscosity sufficient to adhere to moistened tooth enamel while being substantially free of water soluble thickener, said anhydrous mixture being substantially shelf stable due to the absence of water, and wherein said mixture when applied to moistened tooth enamel oxidizes organic compounds without gel blocking A method for mixing such a composition is also shown.

The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and / or an inflammatory disease in an individual using such pharmaceutical compositions.

A baffled insulation product for ventilating air under a roof from an open space is provided comprising an elongated insulation mat having top and bottom major surfaces, the top major surface facing the roof when the product is installed in the open space, the insulation mat having a baffle integral therewith proximate to the top major surface, comprising at least one airflow channel for the ventilating air.

Fuel Cell Having a Hydrophilic Substrate Layer A fuel cell power plant includes a fuel cell having a membrane electrode assembly (MEA), disposed between an anode support plate and a cathode support plate, the anode and / or cathode support plates include a hydrophilic substrate layer having a predetermined pore size. The pressure of the reactant gas streams is greater than the pressure of the coolant stream, such that a greater percentage of the pores within the hydrophilic substrate layer contain reactant gas rather than water. Any water that forms on the cathode side of the MEA will migrate through the cathode support plate and away from the MEA. Controlling the pressure also ensures that the coolant water will continually migrate from the coolant stream toward the anode side of the MEA, thereby preventing the membrane from becoming dry. Proper pore size and a pressure differential between coolant and reactants improves the electrical efficiency of the fuel cell.

A fuel cell power plant includes a fuel cell having a membrane electrode assembly (MEA), disposed between an anode support plate and a cathode support plate, the anode and / or cathode support plates include a hydrophilic substrate layer having a predetermined pore size. The pressure of the reactant gas streams is greater than the pressure of the coolant stream, such that a greater percentage of the pores within the hydrophilic substrate layer contain reactant gas rather than water. Any water that forms on the cathode side of the MEA will migrate through the cathode support plate and away from the MEA. Controlling the pressure also ensures that the coolant water will continually migrate from the coolant stream toward the anode side of the MEA, thereby preventing the membrane from becoming dry. Proper pore size and a pressure differential between coolant and reactants improves the electrical efficiency of the fuel cell.

A fuel cell power plant includes a fuel cell having a membrane electrode assembly (MEA), which is disposed between anode and cathode support plates. Porous water transport plates or the support plates have interdigitated flow channels for the reactant gas streams to pass through and conventional flow channels for coolant streams to pass through. The pressure of the reactant gas streams is greater than the coolant stream which, within the porous water transport plates allows the coolant water to saturate the water transport plates thereby forcing the reactant gases into the anode and cathode support plates. This, in turn, increases the mass transfer of such gases into the support plates, thereby increasing the electrical performance of the fuel cell. Current densities of about 1.6 amps per square centimeter are achieved with air stochiometries of not over 2.50.

A baffled insulation product for ventilating air under a roof from an open space is provided comprising an elongated insulation mat having top and bottom major surfaces, the top major surface facing the roof when the product is installed in the open space, the insulation mat having a baffle integral therewith proximate to the top major surface, comprising at least one airflow channel for the ventilating air.

The present invention generally relates to methods, compositions and uses thereof for enhancing vascularization of a tissue or cell transplant for transplantation into a subject. In particular, one aspect of the present invention provides methods and compositions comprising the use of a population of stromal vascular fraction (SVF) cells to encapsulate or surround a tissue or cell transplant to enhance vascularization of the tissue or cell transplant. Another aspect of the present invention provides methods and compositions for enhancing vascularization of a tissue or cell transplant by combining a population of SVF cells with a tissue or cell transplant to form a transplant mixed with SVF cells. In some embodiments, the SVF cells can be on the surface or embedded within a three-dimensional matrix. In some embodiments, the SVF cells can be generically engineered to secrete therapeutic proteins or pro-angiogenic factors.

A brush having a head with a reservoir formed therein and at least one aperture formed in the head for opening the reservoir to the exterior of the head is provided. The inventive brush also includes a plurality of bristles mounted on the head for transferring material dispensed from the reservoir through the at least one aperture in the head as the brush is drawn through human or animal hair. The inventive brush includes a refill aperture formed in the head and a cap releasably engageable with the refill aperture. The brush may also include a cover movably mounted on the head for closing an aperture in the head with the cover movable between a first position for closing the aperture, and a second position for opening the aperture.

The present invention provides methods for treating tumors, which comprise the step of administering into tumor sites a minus-strand RNA viral vector encoding an immunostimulatory cytokine or cells introduced with the vector. The present invention also provides compositions for treating tumors, which comprise as an active ingredient the minus-strand RNA viral vector encoding an immunostimulatory cytokine or cells introduced with the vector. The present invention also provides kits for treating tumors, which comprise the minus-strand RNA viral vector encoding an immunostimulatory cytokine, and a tumor antigen or a vector expressing the antigen.

The invention relates to the use of the metrology methods and the related apparatus disclosed herein that incorporate thermal treatment devices and methods that improve defect detection. Specifically, in one aspect the invention relates to method of thermally treating a semiconductor wafer such that an acceleration of interstitial defect migration is achieved while leaving vacancy defects substantially unaltered.

An apparatus or biopassage (A) includes a housing (20) dimensioned for receipt in a waterway during an increased flow event. The housing has a passage: (26) that provides a region of reduced flow generally irrespective of the flow external to the passage. A flow disrupter (50) disturbs laminar flow in the waterway above the passage. A preferred embodiment of the disrupter includes surfaces (52, 54) disposed in angled relation relative to a common apex (60) located above a longitudinal opening (30) of the passage. The surfaces include a series of peaks and valleys formed by angled planar portions (56) in one arrangement. A deflector (NC) is positioned upstream of an inlet end (40) of the passage to direct water away from the passage.

The present invention generally relates to methods, compositions and uses thereof for enhancing vascularization of a tissue or cell transplant for transplantation into a subject. In particular, one aspect of the present invention provides methods and compositions comprising the use of a population of stromal vascular fraction (SVF) cells to encapsulate or surround a tissue or cell transplant to enhance vascularization of the tissue or cell transplant. Another aspect of the present invention provides methods and compositions for enhancing vascularization of a tissue or cell transplant by combining a population of SVF cells with a tissue or cell transplant to form a transplant mixed with SVF cells. In some embodiments, the SVF cells can be on the surface or embedded within a three-dimensional matrix. In some embodiments, the SVF cells can be generically engineered to secrete therapeutic proteins or pro-angiogenic factors.

The present invention relates to the use of a component of the plasminogen-activating pathway and use of compounds which have the capacity to activate plasminogen directly or via the plasminogen-activating pathway, for prophylaxis, prevention and treatment of periodontal disease including peri-implantitis, healing of periodontal wounds and prompting oral health in human and non-human subjects.

The present invention relates to the use of a component of the plasminogen-activating pathway and use of compounds which have the capacity to activate plasminogen directly or via the plasminogen-activating pathway, for prophylaxis, prevention and treatment of periodontal disease including peri-implantitis, healing of periodontal wounds and prompting oral health in human and non-human subjects.

The present invention relates to the use of a component of the plasminogen-activating pathway and use of compounds which have the capacity to activate plasminogen directly or via the plasminogen-activating pathway, for prophylaxis, prevention and treatment of periodontal disease including peri-implantitis, healing of periodontal wounds and prompting oral health in human and non-human subjects.

The invention relates to the use of the metrology methods and the related apparatus disclosed herein that incorporate thermal treatment devices and methods that improve defect detection. Specifically, in one aspect the invention relates to method of thermally treating a semiconductor wafer such that an acceleration of interstitial defect migration is achieved while leaving vacancy defects substantially unaltered.

An apparatus or biopassage (A) includes a housing (20) dimensioned for receipt in a waterway during an increased flow event. The housing has a passage: (26) that provides a region of reduced flow generally irrespective of the flow external to the passage. A flow disrupter (50) disturbs laminar flow in the waterway above the passage. A preferred embodiment of the disrupter includes surfaces (52, 54) disposed in angled relation relative to a common apex (60) located above a longitudinal opening (30passage. The surfaces include a series of peaks and valleys formed by angled planar portions (56) in one arrangement. A deflector (NC) is positioned upstream of an inlet end (40) of the passage to direct water away from the passage.

Provided herein is a liposome comprising ribonucleic acid (RNA) molecules, a lipid mixture comprising DOTAP and cholesterol, and iron oxide nanoparticles (IONPs). Also provided herein is a liposome comprising ribonucleic acid (RNA) molecules and a lipid mixture comprising DOTAP and cholesterol, wherein the DOTAP and cholesterol are present in the lipid mixture at a DOTAP:cholesterol ratio of about 3:1 by mass. Related cells comprising the liposome, populations of cells, and compositions are also provided. Methods of making a liposome and methods of using the liposome are further provided.

Disclosed is related to a synthetic peptide consisting of an amino acid sequence of ArgAsnProLeuGluGluThr (SEQ ID NO: 1). Also provided are a pharmaceutical composition benefic to eye care or eye health comprising the peptide, and a method for wound healing using the peptide.

The present invention is directed to a semiconductor multilayer structure and fabrication method thereof. A semiconductor multilayer structure comprises a silicon substrate, and a plurality of semiconductor layers, wherein at least one of the semiconductor layers is an aluminum contained nitride layer; and an indium-containing catalyst is utilized to enhance migration of aluminum in the aluminum contained nitride layer. A fabrication method is also disclosed here. By utilizing the indium-containing catalyst and / or gallium-containing catalyst, the aluminum migration can be enhanced to increase quality and flatness of the aluminum contained nitride buffer layer. Furthermore, the costs and energy consumption can be reduced too.

The purpose of the invention is to provide a novel therapeutic agent for Alzheimer's disease and use thereof. Provided is a therapeutic agent for Alzheimer's disease, which contains a CpG oligodeoxynucleotide structure having a brain migration and improved stability or a salt thereof as an active ingredient.

A brush having a head with a reservoir formed therein and at least one aperture formed in the head for opening the reservoir to the exterior of the head is provided. The inventive brush also includes a plurality of bristles mounted on the head for transferring material dispensed from the reservoir through the at least one aperture in the head as the brush is drawn through human or animal hair. The inventive brush includes a refill aperture formed in the head and a cap releasably engageable with the refill aperture. The brush may also include a cover movably mounted on the head for closing an aperture in the head with the cover movable between a first position for closing the aperture, and a second position for opening the aperture.

The invention described herein relates to methods and compositions for treating cancer in a patient, or a tumor cell, by administering an effective amount of an anti-fugetactic agent and an immunotherapy agent.